Friday, Sep 27, 2024 · SEC filings
What the smart money revealed on Sep 27
219 insider filings came in. We hid 33 planned (10b5-1) sellers and 119 people whose filings were routine, like grants and tax withholding.
3 insiders at BioAge Labs (BIOA) bought $35.4M of stock
Roles: Director. Several insiders buying in the same few days is rare.
IGC Pharma (IGC) Director James Moran bought $200K
588,235 shares on the open market. Not a grant or an option exercise.
Blue Owl Technology Finance Corp. II President Erik Bissonnette bought $118K
7,394 shares on the open market. Not a grant or an option exercise.
Ambac Financial Group (OSG) Director Kristi Matus bought $101K
9,000 shares on the open market. Not a grant or an option exercise.
Butler National (BUKS) Director Michael Loh bought $89.7K
64,850 shares on the open market. Not a grant or an option exercise.
Toll Brothers (TOL) CEO Douglas Yearley Jr. sold $7.73M
Not marked as a planned 10b5-1 sale. Sold 17% of the shares they held directly. Still holds 246,382 shares.
FactSet Research Systems (FDS) EVP Christopher Ellis sold $6.36M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 23,515 shares directly.
Toll Brothers (TOL) CFO Martin Connor sold $777K
Not marked as a planned 10b5-1 sale. Sold 34% of the shares they held directly. Still holds 9,721 shares.
Show 13 more real buys
Show 28 more real sales
13F season
Holdings as of Jun 30, 2024 were due Aug 14
54 funds have filed. 50 filed for the quarter before.
Biggest real insider buys, Sep 21–27
Open-market buys by officers and directors, filed in the 7 days up to Sep 27.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.